Myriad Pharmaceuticals News
Most Popular Myriad Pharmaceuticals Story
Myriad splits diagnostic, pharma business
Myriad Genetics said today that it will proceed with a planned spin-off of it's R&D business form its molecular diagnostics group. The diagnostics business will continue to operate under the name Read more...
Latest Headlines
- October 21, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
